Expression of VEGF, EGF and HGF in earlyand late-stage colorectal cancer
The heterogenous nature of colorectal cancer (CRC) highlights the need for a better understanding of the growth factors that affect tumour growth and cancer progression. The aim of the present study was to evaluate the role of epidermal growth factor (EGF), vascular endothelial growth factor (VEGF)...
Gespeichert in:
| Veröffentlicht in: | Molecular and clinical oncology 2021-12, Vol.15 (6) |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 6 |
| container_start_page | |
| container_title | Molecular and clinical oncology |
| container_volume | 15 |
| creator | Abdulla, Maha-hamadien Sultana, Shaik Asma Vaali-Mohammed, Mansoor- Ali Khayal, Khayal Abdulmalik Al Traiki, Thamer Bin Zubaidi, Ahmad Mohammed Johani, Tariq Al Shakoor, Zahid Obeed, Omar Abdullah-Al |
| description | The heterogenous nature of colorectal cancer (CRC) highlights the need for a better understanding of the growth factors that affect tumour growth and cancer progression. The aim of the present study was to evaluate the role of epidermal growth factor (EGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in the early (I and II) and late (III and IV) stages of CRC. The serum levels and mRNA expression (n=30) of the aforementioned growth factors were measured and immunohistochemistry (n=20) was performed in patients with CRC. Histological examination revealed comparable distribution of early-stage [I: 8 (26.7%) and II: 7 (23.3%)] and late-stage [III: 8 (26.7%) and IV: 7 (23.3%)] CRC. The mean serum concentrations of VEGF during the early (152.9 [+ or -] 14.5 vs. 88.39 [+ or -] 3.99 pg/ml; P=0.001) and late (182.7 [+ or -] 25.8 vs. 88.39 [+ or -] 3.99 pg/ml; P=0.002) stages were significantly higher compared with those in controls. Similarly, the mean serum concentrations of EGF in the early (409.4 [+ or -] 7.96 vs. 153.7 [+ or -] 13.8 pg/ml; P=0.05) and HGF in the late (90.4 [+ or -] 17.4 vs. 56.9 [+ or -] 4.97 pg/ml; P=0.05) stages were significantly higher compared with those in controls. The serum concentrations of VEGF, EGF and HGF were comparable between the early and late stages of CRC. Compared to normal tissues, the mRNA expression of both VEGF (P |
| doi_str_mv | 10.3892/mco.2021.2413 |
| format | Article |
| fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A686125442</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A686125442</galeid><sourcerecordid>A686125442</sourcerecordid><originalsourceid>FETCH-LOGICAL-g672-620b96c0c882e9ed5c4ec48d95bb7b2cc63384603a97712252cd0288810b269c3</originalsourceid><addsrcrecordid>eNptjM1LxDAQxXNQcFn36D3g1dZkmqTJcVm6H7DgZfG6pNNpibSNND3of29FDx6cgXnM4_ceYw9S5IV18DxgzEGAzEHJ4oatQCiXOaXFHduk9CaWcaUA7VbsWH28T5RSiCOPLX-tDvsnvhzux4YfFw0jJz_1n99_72fK0uw74hj7OBHOvufoR6Tpnt22vk-0-dU1u-yry-6YnV8Op932nHWmhMyAqJ1BgdYCOWo0KkJlG6fruqwB0RSFVUYU3pWlBNCAjQBrrRQ1GIfFmj3-1Ha-p2sY2zhPHoeQ8Lo11kjQSsFC5f9QyzY0BIwjtWHx_wS-AOHFWTs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Expression of VEGF, EGF and HGF in earlyand late-stage colorectal cancer</title><source>Spandidos Publications Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Abdulla, Maha-hamadien ; Sultana, Shaik Asma ; Vaali-Mohammed, Mansoor- Ali ; Khayal, Khayal Abdulmalik Al ; Traiki, Thamer Bin ; Zubaidi, Ahmad Mohammed ; Johani, Tariq Al ; Shakoor, Zahid ; Obeed, Omar Abdullah-Al</creator><creatorcontrib>Abdulla, Maha-hamadien ; Sultana, Shaik Asma ; Vaali-Mohammed, Mansoor- Ali ; Khayal, Khayal Abdulmalik Al ; Traiki, Thamer Bin ; Zubaidi, Ahmad Mohammed ; Johani, Tariq Al ; Shakoor, Zahid ; Obeed, Omar Abdullah-Al</creatorcontrib><description>The heterogenous nature of colorectal cancer (CRC) highlights the need for a better understanding of the growth factors that affect tumour growth and cancer progression. The aim of the present study was to evaluate the role of epidermal growth factor (EGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in the early (I and II) and late (III and IV) stages of CRC. The serum levels and mRNA expression (n=30) of the aforementioned growth factors were measured and immunohistochemistry (n=20) was performed in patients with CRC. Histological examination revealed comparable distribution of early-stage [I: 8 (26.7%) and II: 7 (23.3%)] and late-stage [III: 8 (26.7%) and IV: 7 (23.3%)] CRC. The mean serum concentrations of VEGF during the early (152.9 [+ or -] 14.5 vs. 88.39 [+ or -] 3.99 pg/ml; P=0.001) and late (182.7 [+ or -] 25.8 vs. 88.39 [+ or -] 3.99 pg/ml; P=0.002) stages were significantly higher compared with those in controls. Similarly, the mean serum concentrations of EGF in the early (409.4 [+ or -] 7.96 vs. 153.7 [+ or -] 13.8 pg/ml; P=0.05) and HGF in the late (90.4 [+ or -] 17.4 vs. 56.9 [+ or -] 4.97 pg/ml; P=0.05) stages were significantly higher compared with those in controls. The serum concentrations of VEGF, EGF and HGF were comparable between the early and late stages of CRC. Compared to normal tissues, the mRNA expression of both VEGF (P<0.001) and HGF (P<0.01) was upregulated in early-stage and downregulated in late-stage CRC. The expression of EGF remained significantly elevated during both the early and late stages of CRC (P<0.01). Histopathological analyses confirmed increased expression of VEGF in cancerous tissues compared with that in normal tissues. The present study emphasized the need for monitoring the serum levels and tissue expression of growth factors to fully elucidate their role in patients with CRC. Abbreviations: CRC, colorectal cancer; EGF, epidermal growth factor; HGF, hepatocyte growth factor; VEGF, vascular endothelial growth factor Key words: colorectal cancer, early stage, late stage, VEGF, EGF, HGF, expression</description><identifier>ISSN: 2049-9450</identifier><identifier>DOI: 10.3892/mco.2021.2413</identifier><language>eng</language><publisher>Spandidos Publications</publisher><subject>Analysis ; Colorectal cancer ; Development and progression ; Epidermal growth factor ; Immunohistochemistry ; RNA ; Scientific equipment and supplies industry ; Vascular endothelial growth factor</subject><ispartof>Molecular and clinical oncology, 2021-12, Vol.15 (6)</ispartof><rights>COPYRIGHT 2021 Spandidos Publications</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Abdulla, Maha-hamadien</creatorcontrib><creatorcontrib>Sultana, Shaik Asma</creatorcontrib><creatorcontrib>Vaali-Mohammed, Mansoor- Ali</creatorcontrib><creatorcontrib>Khayal, Khayal Abdulmalik Al</creatorcontrib><creatorcontrib>Traiki, Thamer Bin</creatorcontrib><creatorcontrib>Zubaidi, Ahmad Mohammed</creatorcontrib><creatorcontrib>Johani, Tariq Al</creatorcontrib><creatorcontrib>Shakoor, Zahid</creatorcontrib><creatorcontrib>Obeed, Omar Abdullah-Al</creatorcontrib><title>Expression of VEGF, EGF and HGF in earlyand late-stage colorectal cancer</title><title>Molecular and clinical oncology</title><description>The heterogenous nature of colorectal cancer (CRC) highlights the need for a better understanding of the growth factors that affect tumour growth and cancer progression. The aim of the present study was to evaluate the role of epidermal growth factor (EGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in the early (I and II) and late (III and IV) stages of CRC. The serum levels and mRNA expression (n=30) of the aforementioned growth factors were measured and immunohistochemistry (n=20) was performed in patients with CRC. Histological examination revealed comparable distribution of early-stage [I: 8 (26.7%) and II: 7 (23.3%)] and late-stage [III: 8 (26.7%) and IV: 7 (23.3%)] CRC. The mean serum concentrations of VEGF during the early (152.9 [+ or -] 14.5 vs. 88.39 [+ or -] 3.99 pg/ml; P=0.001) and late (182.7 [+ or -] 25.8 vs. 88.39 [+ or -] 3.99 pg/ml; P=0.002) stages were significantly higher compared with those in controls. Similarly, the mean serum concentrations of EGF in the early (409.4 [+ or -] 7.96 vs. 153.7 [+ or -] 13.8 pg/ml; P=0.05) and HGF in the late (90.4 [+ or -] 17.4 vs. 56.9 [+ or -] 4.97 pg/ml; P=0.05) stages were significantly higher compared with those in controls. The serum concentrations of VEGF, EGF and HGF were comparable between the early and late stages of CRC. Compared to normal tissues, the mRNA expression of both VEGF (P<0.001) and HGF (P<0.01) was upregulated in early-stage and downregulated in late-stage CRC. The expression of EGF remained significantly elevated during both the early and late stages of CRC (P<0.01). Histopathological analyses confirmed increased expression of VEGF in cancerous tissues compared with that in normal tissues. The present study emphasized the need for monitoring the serum levels and tissue expression of growth factors to fully elucidate their role in patients with CRC. Abbreviations: CRC, colorectal cancer; EGF, epidermal growth factor; HGF, hepatocyte growth factor; VEGF, vascular endothelial growth factor Key words: colorectal cancer, early stage, late stage, VEGF, EGF, HGF, expression</description><subject>Analysis</subject><subject>Colorectal cancer</subject><subject>Development and progression</subject><subject>Epidermal growth factor</subject><subject>Immunohistochemistry</subject><subject>RNA</subject><subject>Scientific equipment and supplies industry</subject><subject>Vascular endothelial growth factor</subject><issn>2049-9450</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjM1LxDAQxXNQcFn36D3g1dZkmqTJcVm6H7DgZfG6pNNpibSNND3of29FDx6cgXnM4_ceYw9S5IV18DxgzEGAzEHJ4oatQCiXOaXFHduk9CaWcaUA7VbsWH28T5RSiCOPLX-tDvsnvhzux4YfFw0jJz_1n99_72fK0uw74hj7OBHOvufoR6Tpnt22vk-0-dU1u-yry-6YnV8Op932nHWmhMyAqJ1BgdYCOWo0KkJlG6fruqwB0RSFVUYU3pWlBNCAjQBrrRQ1GIfFmj3-1Ha-p2sY2zhPHoeQ8Lo11kjQSsFC5f9QyzY0BIwjtWHx_wS-AOHFWTs</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Abdulla, Maha-hamadien</creator><creator>Sultana, Shaik Asma</creator><creator>Vaali-Mohammed, Mansoor- Ali</creator><creator>Khayal, Khayal Abdulmalik Al</creator><creator>Traiki, Thamer Bin</creator><creator>Zubaidi, Ahmad Mohammed</creator><creator>Johani, Tariq Al</creator><creator>Shakoor, Zahid</creator><creator>Obeed, Omar Abdullah-Al</creator><general>Spandidos Publications</general><scope/></search><sort><creationdate>20211201</creationdate><title>Expression of VEGF, EGF and HGF in earlyand late-stage colorectal cancer</title><author>Abdulla, Maha-hamadien ; Sultana, Shaik Asma ; Vaali-Mohammed, Mansoor- Ali ; Khayal, Khayal Abdulmalik Al ; Traiki, Thamer Bin ; Zubaidi, Ahmad Mohammed ; Johani, Tariq Al ; Shakoor, Zahid ; Obeed, Omar Abdullah-Al</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g672-620b96c0c882e9ed5c4ec48d95bb7b2cc63384603a97712252cd0288810b269c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Analysis</topic><topic>Colorectal cancer</topic><topic>Development and progression</topic><topic>Epidermal growth factor</topic><topic>Immunohistochemistry</topic><topic>RNA</topic><topic>Scientific equipment and supplies industry</topic><topic>Vascular endothelial growth factor</topic><toplevel>online_resources</toplevel><creatorcontrib>Abdulla, Maha-hamadien</creatorcontrib><creatorcontrib>Sultana, Shaik Asma</creatorcontrib><creatorcontrib>Vaali-Mohammed, Mansoor- Ali</creatorcontrib><creatorcontrib>Khayal, Khayal Abdulmalik Al</creatorcontrib><creatorcontrib>Traiki, Thamer Bin</creatorcontrib><creatorcontrib>Zubaidi, Ahmad Mohammed</creatorcontrib><creatorcontrib>Johani, Tariq Al</creatorcontrib><creatorcontrib>Shakoor, Zahid</creatorcontrib><creatorcontrib>Obeed, Omar Abdullah-Al</creatorcontrib><jtitle>Molecular and clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdulla, Maha-hamadien</au><au>Sultana, Shaik Asma</au><au>Vaali-Mohammed, Mansoor- Ali</au><au>Khayal, Khayal Abdulmalik Al</au><au>Traiki, Thamer Bin</au><au>Zubaidi, Ahmad Mohammed</au><au>Johani, Tariq Al</au><au>Shakoor, Zahid</au><au>Obeed, Omar Abdullah-Al</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of VEGF, EGF and HGF in earlyand late-stage colorectal cancer</atitle><jtitle>Molecular and clinical oncology</jtitle><date>2021-12-01</date><risdate>2021</risdate><volume>15</volume><issue>6</issue><issn>2049-9450</issn><abstract>The heterogenous nature of colorectal cancer (CRC) highlights the need for a better understanding of the growth factors that affect tumour growth and cancer progression. The aim of the present study was to evaluate the role of epidermal growth factor (EGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in the early (I and II) and late (III and IV) stages of CRC. The serum levels and mRNA expression (n=30) of the aforementioned growth factors were measured and immunohistochemistry (n=20) was performed in patients with CRC. Histological examination revealed comparable distribution of early-stage [I: 8 (26.7%) and II: 7 (23.3%)] and late-stage [III: 8 (26.7%) and IV: 7 (23.3%)] CRC. The mean serum concentrations of VEGF during the early (152.9 [+ or -] 14.5 vs. 88.39 [+ or -] 3.99 pg/ml; P=0.001) and late (182.7 [+ or -] 25.8 vs. 88.39 [+ or -] 3.99 pg/ml; P=0.002) stages were significantly higher compared with those in controls. Similarly, the mean serum concentrations of EGF in the early (409.4 [+ or -] 7.96 vs. 153.7 [+ or -] 13.8 pg/ml; P=0.05) and HGF in the late (90.4 [+ or -] 17.4 vs. 56.9 [+ or -] 4.97 pg/ml; P=0.05) stages were significantly higher compared with those in controls. The serum concentrations of VEGF, EGF and HGF were comparable between the early and late stages of CRC. Compared to normal tissues, the mRNA expression of both VEGF (P<0.001) and HGF (P<0.01) was upregulated in early-stage and downregulated in late-stage CRC. The expression of EGF remained significantly elevated during both the early and late stages of CRC (P<0.01). Histopathological analyses confirmed increased expression of VEGF in cancerous tissues compared with that in normal tissues. The present study emphasized the need for monitoring the serum levels and tissue expression of growth factors to fully elucidate their role in patients with CRC. Abbreviations: CRC, colorectal cancer; EGF, epidermal growth factor; HGF, hepatocyte growth factor; VEGF, vascular endothelial growth factor Key words: colorectal cancer, early stage, late stage, VEGF, EGF, HGF, expression</abstract><pub>Spandidos Publications</pub><doi>10.3892/mco.2021.2413</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2049-9450 |
| ispartof | Molecular and clinical oncology, 2021-12, Vol.15 (6) |
| issn | 2049-9450 |
| language | eng |
| recordid | cdi_gale_infotracmisc_A686125442 |
| source | Spandidos Publications Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Analysis Colorectal cancer Development and progression Epidermal growth factor Immunohistochemistry RNA Scientific equipment and supplies industry Vascular endothelial growth factor |
| title | Expression of VEGF, EGF and HGF in earlyand late-stage colorectal cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T06%3A05%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20VEGF,%20EGF%20and%20HGF%20in%20earlyand%20late-stage%20colorectal%20cancer&rft.jtitle=Molecular%20and%20clinical%20oncology&rft.au=Abdulla,%20Maha-hamadien&rft.date=2021-12-01&rft.volume=15&rft.issue=6&rft.issn=2049-9450&rft_id=info:doi/10.3892/mco.2021.2413&rft_dat=%3Cgale%3EA686125442%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A686125442&rfr_iscdi=true |